AstraZeneca’s immunotherapy fails in key lung cancer trialAstraZeneca’s immunotherapy combination including its checkpoint inhibitor drug Imfinzi has failed to improve overall survival in a first-line Share XAstraZeneca’s immunotherapy fails in key lung cancer trialhttps://pharmaphorum.com/news/astrazenecas-imfinzi-fails-in-key-lung-cancer-trial/
Blueprint eyes quick filing for GIST drug avapritinibBlueprint Medicines has new data for its lead cancer drug avapritinib in gastrointestinal stromal tumours (GIST) that set Share XBlueprint eyes quick filing for GIST drug avapritinibhttps://pharmaphorum.com/news/blueprint-eyes-quick-filing-for-gist-drug-avapritinib/
Exscientia builds AI capability with Kinetic acquisitionThere is huge focus on the potential of artificial intelligence (AI) in drug discovery – and Exscientia is Share XExscientia builds AI capability with Kinetic acquisitionhttps://pharmaphorum.com/news/exscientia-builds-ai-capability-with-kinetic-acquisition/
Patient centricity is about delivering with, not for, patientsPatient centricity starts with communication and collaboration and these are the only ways to ensure people living with Share XPatient centricity is about delivering with, not for, patientshttps://pharmaphorum.com/views-analysis-patients/patient-centricity-delivering/
Frontiers Health 2018 Live Day OneFrontiers Health is the leading global conference focused on digital disruption and use of technologies within healthcare. The Share XFrontiers Health 2018 Live Day Onehttps://pharmaphorum.com/views-analysis-digital/frontiers-health-2018-live-day-one/
Exclusive – The Future of pharma in a digital worldHow is digital health impacting pharma? An exclusive live broadcast from Frontiers Health 2018 was presented on 15th Share XExclusive – The Future of pharma in a digital worldhttps://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/
CAR-Ts – a new weapon in the fight against cancerCAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies Share XCAR-Ts – a new weapon in the fight against cancerhttps://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
How to achieve digital success in pharma’s communicationsDemystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for Share XHow to achieve digital success in pharma’s communicationshttps://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/
Future-proofing pharma with a multichannel approach to sales and marketingDeploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and Share XFuture-proofing pharma with a multichannel approach to sales and marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/
Metrics to meaning: demonstrating the value of medical communications Share XMetrics to meaning: demonstrating the value of medical communicationshttps://pharmaphorum.com/debates-insight-sales-marketing/metrics-to-meaning-demonstrating-the-value-of-medical-communications/
The devil’s in the e-detail: what HCPs really want from you Share XThe devil’s in the e-detail: what HCPs really want from youhttps://pharmaphorum.com/digital/the-devils-in-the-e-detail-what-hcps-really-want-from-you/
Can simulated datasets unlock the potential of patient data? Share XCan simulated datasets unlock the potential of patient data?https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/
Intelligent HCP engagement in Europe – what do doctors want?The opportunity to engage with HCPs digitally has never been more prevalent. We are witnessing a desire from Share XIntelligent HCP engagement in Europe – what do doctors want?https://pharmaphorum.com/digital/intelligent-hcp-engagement-europe/
Understanding blockchain – a practical guide for life sciences companiesWithin the life science industry, uptake of blockchain is in the early stages, but with investment levels in Share XUnderstanding blockchain – a practical guide for life sciences companieshttps://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/
The innovation challenge: realising the true potential of digitalDigital transformation; it would be easy to assume that it is widespread across the life science industry, and Share XThe innovation challenge: realising the true potential of digitalhttps://pharmaphorum.com/digital/insights-digital/innovation-challenge-true-potential-digital/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success Share XEisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successhttps://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
Part three: Oncology shaping the future of personalised healthcare Share XPart three: Oncology shaping the future of personalised healthcarehttps://pharmaphorum.com/video/part-three-oncology-shaping-future-personalised-healthcare/
3rd Microbiome Movement – Drug Development Europe Share X3rd Microbiome Movement – Drug Development Europehttps://pharmaphorum.com/partner-content/3rd-microbiome-movement-drug-development-europe-2/
Pharmaceutical Microbiology UK Speaker Interview Released from Fresenius Kabi AB Share XPharmaceutical Microbiology UK Speaker Interview Released from Fresenius Kabi ABhttps://pharmaphorum.com/partner-content/pharmaceutical-microbiology-uk-speaker-interview-released-from-fresenius-kabi-ab/
J+D, Pharma Forecasting Experts Partner with Epiphany, Oncology Data Experts Share XJ+D, Pharma Forecasting Experts Partner with Epiphany, Oncology Data Expertshttps://pharmaphorum.com/partner-content/jd-pharma-forecasting-experts-partner-with-epiphany-oncology-data-experts/
Parallel Trade for Pharma: Addressing Competition law and FMD challenges Share XParallel Trade for Pharma: Addressing Competition law and FMD challengeshttps://pharmaphorum.com/partner-content/parallel-trade-for-pharma-addressing-competition-law-and-fmd-challenges/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
Ashfield Healthcare Communications appoints new Global Commercial Director Share XAshfield Healthcare Communications appoints new Global Commercial Directorhttps://pharmaphorum.com/partner-content/ashfield-healthcare-communications-appoints-new-global-commercial-director/
